/IAN.CN
IAN.CN Stock - iAnthus Capital Holdings, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericCNQ
$0.01+0.00%
+$0.00 (+0.00%) • Dec 22
58
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.13
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IAN.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.00
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.46
52W High$0.01
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $167.57M | $159.24M | $163.21M | $203.02M | $151.67M |
| Gross Profit | $75.11M | $63.17M | $74.43M | $111.28M | $86.68M |
| Gross Margin | 44.8% | 39.7% | 45.6% | 54.8% | 57.2% |
| Operating Income | $-8,513,000 | $-40,710,000 | $-70,220,000 | $-14,111,000 | $-51,652,000 |
| Net Income | $-7,636,000 | $-76,621,000 | $-449,391,000 | $-76,248,000 | $-310,031,000 |
| Net Margin | -4.6% | -48.1% | -275.3% | -37.6% | -204.4% |
| EPS | $-0.00 | $-0.01 | $-0.07 | $-0.44 | $-1.81 |
Company Overview
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IAN.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 18, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 12, 2025 | — | $0.00 | — | — |
Q1 2025 | Mar 24, 2025 | — | $0.01 | — | — |
Q4 2024 | Nov 12, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 14, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 28, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 9, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 15, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 30, 2023 | — | $-0.01 | — | — |
Q4 2022 | Nov 8, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.84 | — | — |
Q2 2022 | May 12, 2022 | — | $-0.02 | — | — |
Q1 2022 | Mar 18, 2022 | — | $-0.06 | — | — |
Q4 2021 | Nov 8, 2021 | — | $-0.04 | — | — |
Q3 2021 | Aug 10, 2021 | — | $-0.04 | — | — |
Q2 2021 | May 17, 2021 | — | $-0.05 | — | — |
Latest News
Loading news...
Frequently Asked Questions about IAN.CN
What is IAN.CN's current stock price?
iAnthus Capital Holdings, Inc. (IAN.CN) is currently trading at $0.01 per share. The stock has moved +0.00% today.
What is the analyst price target for IAN.CN?
No analyst price targets are currently available for this stock.
What sector is iAnthus Capital Holdings, Inc. in?
iAnthus Capital Holdings, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the CNQ exchange.
What is IAN.CN's market cap?
iAnthus Capital Holdings, Inc. has a market capitalization of $0.03 billion, making it a small-cap company.
Does IAN.CN pay dividends?
No, iAnthus Capital Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCBST.NE
The Cannabist Company Holdings Inc.
$0.09
Mkt Cap: $0.0B
CWEB.TO
Charlotte's Web Holdings, Inc.
$0.38
Mkt Cap: $0.1B
CXXI.CN
C21 Investments Inc.
$0.44
Mkt Cap: $0.1B
DB.V
Decibel Cannabis Company Inc.
$0.10
Mkt Cap: $0.1B
EPIC.CN
1CM Inc.
$0.20
Mkt Cap: $0.0B
INNO.CN
InnoCan Pharma Corporation
$7.50
Mkt Cap: $0.0B
LEEF.CN
Leef Brands Inc.
$0.22
Mkt Cap: $0.0B
MRMD.CN
MariMed Inc.
$0.14
Mkt Cap: $0.1B
PLTH.CN
Planet 13 Holdings Inc.
$0.30
Mkt Cap: $0.1B
VEXT.CN
Vext Science, Inc.
$0.30
Mkt Cap: $0.1B
Explore stocks similar to IAN.CN for comparison